P

Porton Pharma Solutions Ltd
SZSE:300363

Watchlist Manager
Porton Pharma Solutions Ltd
SZSE:300363
Watchlist
Price: 17.2 CNY -5.29% Market Closed
Market Cap: 9.4B CNY
Have any thoughts about
Porton Pharma Solutions Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is 20.26 CNY. Compared to the current market price of 17.2 CNY, Porton Pharma Solutions Ltd is Undervalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
20.26 CNY
Undervaluation 15%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation Backtest
Porton Pharma Solutions Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Porton Pharma Solutions Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Porton Pharma Solutions Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Porton Pharma Solutions Ltd

Provide an overview of the primary business activities
of Porton Pharma Solutions Ltd.

What unique competitive advantages
does Porton Pharma Solutions Ltd hold over its rivals?

What risks and challenges
does Porton Pharma Solutions Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Porton Pharma Solutions Ltd.

Provide P/S
for Porton Pharma Solutions Ltd.

Provide P/E
for Porton Pharma Solutions Ltd.

Provide P/OCF
for Porton Pharma Solutions Ltd.

Provide P/FCFE
for Porton Pharma Solutions Ltd.

Provide P/B
for Porton Pharma Solutions Ltd.

Provide EV/S
for Porton Pharma Solutions Ltd.

Provide EV/GP
for Porton Pharma Solutions Ltd.

Provide EV/EBITDA
for Porton Pharma Solutions Ltd.

Provide EV/EBIT
for Porton Pharma Solutions Ltd.

Provide EV/OCF
for Porton Pharma Solutions Ltd.

Provide EV/FCFF
for Porton Pharma Solutions Ltd.

Provide EV/IC
for Porton Pharma Solutions Ltd.

Show me price targets
for Porton Pharma Solutions Ltd made by professional analysts.

What are the Revenue projections
for Porton Pharma Solutions Ltd?

How accurate were the past Revenue estimates
for Porton Pharma Solutions Ltd?

What are the Net Income projections
for Porton Pharma Solutions Ltd?

How accurate were the past Net Income estimates
for Porton Pharma Solutions Ltd?

What are the EPS projections
for Porton Pharma Solutions Ltd?

How accurate were the past EPS estimates
for Porton Pharma Solutions Ltd?

What are the EBIT projections
for Porton Pharma Solutions Ltd?

How accurate were the past EBIT estimates
for Porton Pharma Solutions Ltd?

Compare the revenue forecasts
for Porton Pharma Solutions Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Porton Pharma Solutions Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Porton Pharma Solutions Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Porton Pharma Solutions Ltd compared to its peers.

Compare the P/E ratios
of Porton Pharma Solutions Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Porton Pharma Solutions Ltd with its peers.

Analyze the financial leverage
of Porton Pharma Solutions Ltd compared to its main competitors.

Show all profitability ratios
for Porton Pharma Solutions Ltd.

Provide ROE
for Porton Pharma Solutions Ltd.

Provide ROA
for Porton Pharma Solutions Ltd.

Provide ROIC
for Porton Pharma Solutions Ltd.

Provide ROCE
for Porton Pharma Solutions Ltd.

Provide Gross Margin
for Porton Pharma Solutions Ltd.

Provide Operating Margin
for Porton Pharma Solutions Ltd.

Provide Net Margin
for Porton Pharma Solutions Ltd.

Provide FCF Margin
for Porton Pharma Solutions Ltd.

Show all solvency ratios
for Porton Pharma Solutions Ltd.

Provide D/E Ratio
for Porton Pharma Solutions Ltd.

Provide D/A Ratio
for Porton Pharma Solutions Ltd.

Provide Interest Coverage Ratio
for Porton Pharma Solutions Ltd.

Provide Altman Z-Score Ratio
for Porton Pharma Solutions Ltd.

Provide Quick Ratio
for Porton Pharma Solutions Ltd.

Provide Current Ratio
for Porton Pharma Solutions Ltd.

Provide Cash Ratio
for Porton Pharma Solutions Ltd.

What is the historical Revenue growth
over the last 5 years for Porton Pharma Solutions Ltd?

What is the historical Net Income growth
over the last 5 years for Porton Pharma Solutions Ltd?

What is the current Free Cash Flow
of Porton Pharma Solutions Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Porton Pharma Solutions Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Porton Pharma Solutions Ltd

Current Assets 3.1B
Cash & Short-Term Investments 1.5B
Receivables 702.1m
Other Current Assets 944.6m
Non-Current Assets 5.8B
Long-Term Investments 393.1m
PP&E 4.2B
Intangibles 565m
Other Non-Current Assets 577.6m
Current Liabilities 1.4B
Accounts Payable 617.5m
Accrued Liabilities 118.9m
Short-Term Debt 256.6m
Other Current Liabilities 429.2m
Non-Current Liabilities 2.1B
Long-Term Debt 1.7B
Other Non-Current Liabilities 444.3m
Efficiency

Earnings Waterfall
Porton Pharma Solutions Ltd

Revenue
2.8B CNY
Cost of Revenue
-2.2B CNY
Gross Profit
566.5m CNY
Operating Expenses
-949.4m CNY
Operating Income
-382.9m CNY
Other Expenses
-8.6m CNY
Net Income
-391.4m CNY

Free Cash Flow Analysis
Porton Pharma Solutions Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Porton Pharma Solutions Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Negative Operating Income
46/100
Profitability
Score

Porton Pharma Solutions Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Porton Pharma Solutions Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
60/100
Solvency
Score

Porton Pharma Solutions Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Porton Pharma Solutions Ltd

Wall Street analysts forecast Porton Pharma Solutions Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 27.03 CNY with a low forecast of 20.2 CNY and a high forecast of 34.65 CNY.

Lowest
Price Target
20.2 CNY
17% Upside
Average
Price Target
27.03 CNY
57% Upside
Highest
Price Target
34.65 CNY
101% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Porton Pharma Solutions Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Porton Pharma Solutions Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Porton Pharma Solutions Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

9.4B CNY

Dividend Yield

2.83%

Description

Porton Pharma Solutions Ltd. engages in the research and development and manufacture of pharmaceutical products and active pharmaceutical ingredients. The company is headquartered in Chongqing, Chongqing and currently employs 3,782 full-time employees. The company went IPO on 2014-01-29. The firm is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The firm operates its businesses in Europe, North America, Asia and China, among others.

Contact

CHONGQING
Chongqing
R & D Center of New Drug Outsourcing Service Base, Porton Pharma Solutions Ltd., Fangzheng Avenue, Water and Soil Park, Beibei District
+862365936900
www.porton.cn

IPO

2014-01-29

Employees

3 782

Officers

Chairman & GM
Mr. Nianfeng Ju
Deputy GM & CFO
Mr. Hui Chen
Senior Deputy GM & COO
Mr. Yinchun Bai
Deputy General Manager & Secretary
Ms. Pi Wei
Deputy General Manager
Mr. Yuanming Huang

See Also

Discover More
What is the Intrinsic Value of one Porton Pharma Solutions Ltd stock?

The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is 20.26 CNY.

Is Porton Pharma Solutions Ltd stock undervalued or overvalued?

Compared to the current market price of 17.2 CNY, Porton Pharma Solutions Ltd is Undervalued by 15%.

Back to Top